Peficitinib: First Global Approval
This article summarizes the milestones in the development of peficitinib leading to this first approval as a treatment for rheumatoid arthritis in patients who have an inadequate response to conventional therapies.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Clinical Trials | Drugs & Pharmacology | Japan Health | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology